Assertio Therapeutics Inc (ASRT) — Capital Reinvestment Ratio
Assertio Therapeutics Inc (ASRT) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($5.71 Million) in capital expenditures ($180.00K). Check ASRT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Assertio Therapeutics Inc Capital Reinvestment Ratio (2005–2023)
This chart tracks Assertio Therapeutics Inc's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Assertio Therapeutics Inc (ASRT) cash flow conversion.
Annual Capital Reinvestment Ratio for Assertio Therapeutics Inc (2005–2023)
Year-by-year Capital Reinvestment Ratio for Assertio Therapeutics Inc from 2005 to 2023. See ASRT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $49.60 Million | $628.00K | ▲ +263.2% |
| 2022 | 0.00x | $78.60 Million | $274.00K | ▼ -63.7% |
| 2021 | 0.01x | $5.52 Million | $53.00K | ▼ -41.4% |
| 2019 | 0.02x | $90.47 Million | $1.48 Million | ▼ -78.5% |
| 2018 | 0.08x | $72.50 Million | $5.51 Million | ▲ +609.1% |
| 2017 | 0.01x | $62.17 Million | $666.00K | ▼ -75.5% |
| 2016 | 0.04x | $65.50 Million | $2.86 Million | ▼ -76.5% |
| 2015 | 0.19x | $143.89 Million | $26.71 Million | ▼ -7.7% |
| 2013 | 0.20x | $9.75 Million | $1.96 Million | ▲ +1561.4% |
| 2011 | 0.01x | $57.65 Million | $698.00K | ▼ -96.5% |
| 2009 | 0.34x | $1.84 Million | $629.00K | ▲ +346.2% |
| 2008 | 0.08x | $3.35 Million | $257.00K | ▲ +620.8% |
| 2007 | 0.01x | $14.66 Million | $156.00K | ▼ -61.2% |
| 2005 | 0.03x | $28.82 Million | $791.25K | — |